U2Bio Co., Ltd. (KOSDAQ:221800)
South Korea · Delayed Price · Currency is KRW 26,850
+900 (3.47%)
At close: Feb 26, 2026
682.80% (1Y)
| Market Cap | 427.79B +1,191.3% |
| Revenue (ttm) | 25.59B -2.6% |
| Net Income | -2.99B |
| EPS | -265.81 |
| Shares Out | 15.93M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 100.00 (0.37%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 7,770,604 |
| Average Volume | 3,298,192 |
| Open | 25,700 |
| Previous Close | 25,950 |
| Day's Range | 25,200 - 32,800 |
| 52-Week Range | 2,850 - 32,800 |
| Beta | -0.12 |
| RSI | 81.54 |
| Earnings Date | n/a |